Early Phase 1 Trial Investigating Postoperative Treatment Selection After Preoperative Chemotherapy for Gastric Cancers

Share this content:
Researchers are seeking to determine the feasibility of receiving either postoperative chemoradiation or chemotherapy, based on nodal status at surgery.
Researchers are seeking to determine the feasibility of receiving either postoperative chemoradiation or chemotherapy, based on nodal status at surgery.

Title: Postoperative Chemoradiation or Chemotherapy After Preoperative Chemotherapy for Gastric Cancers (GABLE) (ClinicalTrials.gov Identifier: NCT03515941)

Principle Investigator: Brandon G. Smaglo, MD, FACP, Baylor College of Medicine, Houston, Texas

Description: This is an early phase 1 open-label, stratified, 2-arm trial. Initially, all enrolled patients will receive standard preoperative chemotherapy and surgical resection for gastric cancer. After initial treatment, patients with node-negative disease will receive standard postoperative chemotherapy and patients with node-positive disease will receive standard postoperative chemoradiation.

In order to be eligible, patients must have pathologically proven adenocarcinoma of the stomach or gastroesophageal (GE)-junction, stage M0, as established by both imaging and surgical pathologic staging, have previously completed 3 cycles of neoadjuvant chemotherapy, and have undergone a surgical resection with definitive intent. Furthermore, patients must be assessed and verified as good candidates for adjuvant chemotherapy or chemoradiation, have diagnostic biopsy tissue that is available for genetic testing, and must be older than 18 years and be able to provide informed consent.

Continue Reading Below

The primary objective of this trial is to determine the feasibility of receiving either postoperative chemoradiation or chemotherapy, based on nodal status at surgery, following preoperative chemotherapy. The researchers are seeking, as a secondary end point, to evaluate the rate of cancer recurrence after nodal status is used as the basis for treatment assignment.

For more study information, including exclusion and inclusion criteria, study locations, and contact information, visit https://clinicaltrials.gov/ct2/show/NCT03515941.

Status: The trial is open and recruiting patients as of May 31, 2018. The estimated enrollment for the trial is 40 patients.

Reference

  1. Clinicaltrials.gov. Postoperative chemoradiation or chemotherapy after preoperative chemotherapy for gastric cancers (GABLE). NCT03515941. https://clinicaltrials.gov/ct2/show/NCT03515941. Accessed December 17, 2018.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs